Related references
Note: Only part of the references are listed.Bone turnover markers after the menopause: T-score approach
Fatma Gossiel et al.
BONE (2018)
Teriparatide treatment exerts differential effects on the central and peripheral skeleton: results from the MOAT study
M. A. Paggiosi et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Effects of abaloparatide-SC (BA058) on bone histology and histomorphometry: The ACTIVE phase 3 trial
Carolina A. Moreira et al.
BONE (2017)
Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling
Gary Hattersley et al.
ENDOCRINOLOGY (2016)
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis A Randomized Clinical Trial
Paul D. Miller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
PINP as an aid for monitoring patients treated with teriparatide
Mika Tsujimoto et al.
BONE (2011)
Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide
A. Blumsohn et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
S. Vasikaran et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Rapid and robust response of biochemical markers of bone formation to teriparatide therapy
Sarah J. Glover et al.
BONE (2009)
Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis
DC Bauer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Development of an algorithm for using PINP to monitor treatment of patients with teriparatide
R Eastell et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis
PQ Chen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis
NE Lane et al.
OSTEOPOROSIS INTERNATIONAL (2000)
Share Paper
